Page last updated: 2024-09-05

deferasirox and Vitamin D Deficiency

deferasirox has been researched along with Vitamin D Deficiency in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allegra, S; Arduino, A; Cusato, J; D'Avolio, A; De Francia, S; De Nicolò, A; Longo, F; Massano, D; Piga, A; Pirro, E	1
Al Rawas, A; Bashir, W; Pathare, A; Tony, S; Wali, Y; Zachariah, M	1

Other Studies

2 other study(ies) available for deferasirox and Vitamin D Deficiency

Article	Year
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. The pharmacogenomics journal, 2018, 05-22, Volume: 18, Issue:3 Topics: Adolescent; Adult; Alleles; beta-Thalassemia; Deferasirox; Female; Genotype; Humans; Liver; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Vitamin D-Binding Protein; Vitamin D3 24-Hydroxylase; Young Adult	2018
Comparative assessment of deferiprone and deferasirox in thalassemia major patients in the first two decades-single centre experience. Pediatric hematology and oncology, 2013, Volume: 30, Issue:2 Topics: Administration, Oral; Adolescent; Age Factors; Benzoates; beta-Thalassemia; Child; Child, Preschool; Cross-Sectional Studies; Deferasirox; Deferiprone; Female; Ferritins; Humans; Infant; Iron Chelating Agents; Male; Pyridones; Retrospective Studies; Triazoles; Vitamin D Deficiency	2013

Article

Year

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes.

The pharmacogenomics journal, 2018, 05-22, Volume: 18, Issue:3

Topics: Adolescent; Adult; Alleles; beta-Thalassemia; Deferasirox; Female; Genotype; Humans; Liver; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Vitamin D-Binding Protein; Vitamin D3 24-Hydroxylase; Young Adult

2018

Comparative assessment of deferiprone and deferasirox in thalassemia major patients in the first two decades-single centre experience.

Pediatric hematology and oncology, 2013, Volume: 30, Issue:2

Topics: Administration, Oral; Adolescent; Age Factors; Benzoates; beta-Thalassemia; Child; Child, Preschool; Cross-Sectional Studies; Deferasirox; Deferiprone; Female; Ferritins; Humans; Infant; Iron Chelating Agents; Male; Pyridones; Retrospective Studies; Triazoles; Vitamin D Deficiency

2013